-
公开(公告)号：WO2003017962A1
公开(公告)日：2003-03-06
申请号：PCT/EP2002/009166
申请日：2002-08-15
Applicant: UNILEVER N.V. , UNILEVER PLC , HINDUSTAN LEVER LTD
Inventor： CROMWELL, Victoria , FREUNSCHT, Peter , HALL, Peter, John , LITTLEWOOD, David, Thomas
IPC: A61K7/24
CPC classification number: A61K8/19 , A61K8/27 , A61K8/365 , A61K8/37 , A61K8/463 , A61K2800/52 , A61Q11/00
Abstract: Oral composition comprising an alkyl hydroxybenzoate represented by formula I, wherein R represents a straight chain alkyl group comprising at least eight carbon atoms.
Abstract translation: 包含由式I表示的羟基苯甲酸烷基酯的口服组合物，其中R表示包含至少8个碳原子的直链烷基。
-
Patent Agency Ranking
公开(公告)号：WO2003017965A1
公开(公告)日：2003-03-06
申请号：PCT/EP2002/009169
申请日：2002-08-15
Applicant: UNILEVER N.V. , UNILEVER PLC , HINDUSTAN LEVER LTD
IPC: A61K7/24
Abstract: Oral composition comprising: (a) an alkyl hydroxybenzoate represented by formula (1) wherein R represents an alkyl group comprising at least five carbon atoms, and (b) from 1.3 to 1.7% by weight of the composition a surfactant.
Abstract translation: 口服组合物，其包含：（a）由式（1）表示的羟基苯甲酸烷基酯，其中R表示包含至少五个碳原子的烷基，和（b）1.3至1.7重量％的组合物表面活性剂。
-
公开(公告)号：WO2003017964A1
公开(公告)日：2003-03-06
申请号：PCT/EP2002/009168
申请日：2002-08-15
Applicant: UNILEVER N.V. , UNILEVER PLC , HINDUSTAN LEVER LTD
Inventor： HALL, Peter, John , LITTLEWOOD, David, Thomas
IPC: A61K7/24
CPC classification number: A61K8/19 , A61K8/27 , A61K8/365 , A61K8/37 , A61K8/463 , A61K2800/52 , A61Q11/00 , A61Q11/02
Abstract: Oral composition comprising:(a) an alkyl hydroxybenzoate represented by Formula (1): wherein R represents an alkyl group comprising at least five carbon atoms, and(b) said composition having an alkaline pH.
Abstract translation: 口服组合物，其包含：（a）由式（1）表示的羟基苯甲酸烷基酯：其中R表示包含至少5个碳原子的烷基，和（b）所述组合物具有碱性pH。
-
公开(公告)号：WO2003017963A1
公开(公告)日：2003-03-06
申请号：PCT/EP2002/009167
申请日：2002-08-15
Applicant: UNILEVER N.V. , UNILEVER PLC , HINDUSTAN LEVER LTD
Inventor： CROMWELL, Victoria , FREUNSCHT, Peter , HALL, Peter, John
IPC: A61K7/24
CPC classification number: A61K8/19 , A61K8/27 , A61K8/365 , A61K8/37 , A61K8/463 , A61K2800/52 , A61Q11/00
Abstract: Oral composition comprising an alkyl hydroxybenzoate represented by formula (I): wherein R represents an alkyl group comprising at least five carbon atoms, characterised in that the composition additionally comprises a divalent metal salt.
Abstract translation: 包含由式（I）表示的羟基苯甲酸烷基酯的口服组合物：其中R表示包含至少五个碳原子的烷基，其特征在于所述组合物另外包含二价金属盐。
-
公开(公告)号：WO1997000932A1
公开(公告)日：1997-01-09
申请号：PCT/EP1996002586
申请日：1996-06-14
Applicant: UNILEVER N.V. , UNILEVER PLC
Inventor： UNILEVER N.V. , UNILEVER PLC , VAN DIJK, Willem, Robert , OUWENDIJK, Marya , HALL, Peter, John
IPC: C11D03/386
CPC classification number: C11D3/38663 , C11D1/30
Abstract: Enzymatic compositions with improved storage stability of the enzymes contained therein are obtained by including an enzyme stabiliser, preferably by way of a particular process.
Abstract translation: 通过包括酶稳定剂，优选通过特定方法获得其中所含酶的储存稳定性提高的酶组合物。
-
公开(公告)号：WO2004047782A1
公开(公告)日：2004-06-10
申请号：PCT/EP2003/012555
申请日：2003-11-10
Applicant: UNILEVER N.V. , UNILEVER PLC , HINDUSTAN LEVER LIMITED
Inventor： HALL, Peter, John
IPC: A61K7/16
Abstract: An oral composition comprising a compound of Formula (I), wherein: at least one R is a metal or ammonium salt of -OH, the remaining R groups independently selected from the group consisting of: H, F, Cl, Br, -OH, C1 to C 5 -alkyl, -C(O)H, and -C(O)-C1 to C 5 -alkyl and z takes a value of from 1 to 5; R' is selected from the group consisting of: H, -OH, F, Cl, Br, I, and C 1 -C 6 alkyl and n is an integer of from 0 to 12; wherein X is a group selected from -C(O)-NH-R'', -R'', -C(O-R'',-C(O)O-R'', and -SO 2 -R''; and R'' is selected from the group consisting of: -C 5 - 16 alkyl or -CH 2 C 6 H 6 .
Abstract translation: 一种口服组合物，其包含式（I）化合物，其中：至少一个R是-OH的金属或铵盐，其余R基团独立地选自：H，F，Cl，Br，-OH ，C 1〜C 5 - 烷基，-C（O）H和-C（O）-C 1〜C 5 - 烷基，z取值为1〜5; R'选自：H，-OH，F，Cl，Br，I和C 1 -C 6烷基，n是0至12的整数; 其中X是选自-C（O）-NH-R“，-R”，-C（O-R“， - C（O）O-R”和-SO 2 -R' ';且R“选自：-C 1-6 - 烷基或-CH 2 C 6 H 6。
-
-
-
-
-
Search Results
6
records
(took 0.014 seconds)
